Participants acknowledge that COVID-19 is an infectious virus that spreads easily through person-to-person contact and may cause serious illness to individuals who are unvaccinated and/or have certain medical risk factors. Federal and state public health authorities and ASMS have issued basic health and safety guidelines aimed at mitigating the spread of the virus. Participants understand attending ASMS Asilomar Conference 2022 may increase the risk of contracting COVID-19. ASMS in no way warrants that the protective measures prescribed for ASMS Asilomar Conference will completely prevent exposure to the COVID-19 virus. Participants agree to follow all public health and safety guidelines to attend ASMS and freely and voluntarily assume the risk of COVID-19 exposure and infection.
ASMS Health & Safety Policies for the Asilomar Conference
Because of the COVID-19 pandemic, local conditions and safety guidelines are constantly evolving. We are closely monitoring the current state, federal and local COVID-19 guidelines for in-person gatherings and travel restrictions since a lot can change between now and October 2022. The policies listed below are subject to change.
Vaccination Required AND Proof of Negative Covid Test for All Participants
All participants (including guests that wish to enter the conference room, Merrill Hall) must show proof of full COVID-19 vaccination AND proof of negative Covid test within 24 hours of arrival in order to pick-up their name badge at the Asilomar Conference. Remember to bring proof of vaccination and your negative test result with you to the conference.
Approved vaccinations. Participants must be fully vaccinated with a vaccine approved by the Food and Drug Administration (FDA) or World Health Organization (WHO). Following current Centers for Disease Control and Prevention (CDC) guidelines, a person is considered fully vaccinated if they satisfy one of the following requirements:
- 2 weeks after their second dose in a 2-dose series, such as the Pfizer and Moderna vaccines.
- 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine.
Additionally, COVID-19 vaccines authorized for emergency use by the World Health Organization (i.e., AstraZeneca/Oxford, Covishield, Sinopharm, and Sinovac), on or before September 7, 2022, are approved for attendance to the conference. Please refer to the list of approved vaccines with WHO EUL/PQ evaluation status.
Negative Covid test result. Negative test result must be dated within 24 hours of arrival at the conference. Rapid antigen / Lateral flow or PCR test results are acceptable. If using a home test, please take a photo of the negative test result and include dated material (for example, a receipt from a local store purchase). We encourage all attendees to bring home tests with them to insure a test can be performed in the 24 hours prior to name badge pick-up.
Masks Required at all Asilomar Conference Events
ASMS will require masks at the conference regardless of local ordinances. Masks must completely cover your mouth and nose and fit snugly without gaps. Disposable masks will be available onsite. Participants are strongly encouraged to bring their own supply of high-quality N95, KF94, or similar, masks for their personal use during the conference.
Health Attestation to be Signed at Name Badge Pick-up
At name badge pick-up participants must attest they have not:
- Been diagnosed with or tested positive for COVID-19 within the past 10 days.
- Been directed to self-isolate by a public health authority or healthcare provider due to potential exposure to COVID-19 within the past 10 days.
- Had any symptoms associated with COVID-19 infection, nor had any symptoms in the past 10 days, including: fever of over 100.0; cough (not attributed to a pre-existing condition); shortness of breath or difficulty breathing; fatigue; muscle or body aches; loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; and/or diarrhea.
- Had close contact (within 6 feet) with anyone under known quarantine or diagnosed with COVID-19 or showing symptoms of COVID-19 in the past 10 days.
A single sheet attestation form will be completed by each participant.
Centers for Disease Control and Prevention
California Department of Public Health
World Health Organization (WHO)